Emergent BioSolutions Inc (EBS)
2.18
-0.11
(-4.80%)
USD |
NYSE |
Apr 24, 16:00
2.17
-0.01
(-0.46%)
After-Hours: 20:00
Emergent BioSolutions Free Cash Flow (Quarterly): 20.70M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.70M |
| September 30, 2023 | 47.40M |
| June 30, 2023 | -126.90M |
| March 31, 2023 | -199.10M |
| December 31, 2022 | 69.20M |
| September 30, 2022 | -101.90M |
| June 30, 2022 | -47.70M |
| March 31, 2022 | -69.50M |
| December 31, 2021 | 282.30M |
| September 30, 2021 | -38.50M |
| June 30, 2021 | -96.70M |
| March 31, 2021 | -51.00M |
| December 31, 2020 | 209.10M |
| September 30, 2020 | 59.50M |
| June 30, 2020 | 92.80M |
| March 31, 2020 | 33.60M |
| December 31, 2019 | 86.00M |
| September 30, 2019 | -18.40M |
| June 30, 2019 | -49.90M |
| March 31, 2019 | 83.40M |
| December 31, 2018 | -186.60M |
| September 30, 2018 | 147.90M |
| June 30, 2018 | 21.00M |
| March 31, 2018 | -12.60M |
| December 31, 2017 | 65.07M |
| Date | Value |
|---|---|
| September 30, 2017 | 22.16M |
| June 30, 2017 | 44.70M |
| March 31, 2017 | 21.37M |
| December 31, 2016 | -32.61M |
| September 30, 2016 | 10.08M |
| June 30, 2016 | -23.03M |
| March 31, 2016 | 23.96M |
| December 31, 2015 | -10.05M |
| September 30, 2015 | 90.81M |
| June 30, 2015 | -8.096M |
| March 31, 2015 | -74.96M |
| December 31, 2014 | 35.77M |
| September 30, 2014 | 73.70M |
| June 30, 2014 | 6.009M |
| March 31, 2014 | -33.84M |
| December 31, 2013 | 1.04M |
| September 30, 2013 | 39.83M |
| June 30, 2013 | 26.38M |
| March 31, 2013 | -12.30M |
| December 31, 2012 | -51.92M |
| September 30, 2012 | 36.46M |
| June 30, 2012 | 9.746M |
| March 31, 2012 | -8.489M |
| December 31, 2011 | 17.06M |
| September 30, 2011 | -12.70M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-199.10M
Minimum
Mar 2023
282.30M
Maximum
Dec 2021
5.316M
Average
-18.40M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Avid Bioservices Inc | -1.224M |
| Viking Therapeutics Inc | -17.64M |
| FibroGen Inc | -18.57M |
| Avinger Inc | -3.389M |
| RAPT Therapeutics Inc | -27.82M |